Endometriosis, malaria & leukemia treatments: 5 FDA approvals this week

Here are the five latest drugs or medical devices approved by the FDA since July 20:

1. The Magtrace and Sentimag Magnetic Localization System is used to guide lymph node biopsies in breast cancer patients undergoing a mastectomy.

2. Orlissa is the first treatment approved for endometriosis in 10 years.

3.  Krintafel is a one-dose treatment to prevent malaria relapses.

4. Tibsovo tablets are used to treat relapsed or refractory acute myeloid leukemia in adult patients with a specific genetic mutation.

5. Pfizer's Nivestym is a biosimilar version of Amgen's Neupogen, both of which are used to boost white blood cell counts in cancer patients.

More articles on supply chain:
Reuters: Amazon in talks to buy Indian pharmacy chain
London drugmaker boosts injectable opioid supply for US hospitals amid shortage
Bayer pulls birth control implant Essure from US market: 5 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars